https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
246
 
downloads
6
CITE
How to cite this poster:
Navarro A, Saldaña MT, Pérez C et al. Effect of pregabalin on cost and clinical consequences in gabapentin-refractory patients with peripheral neuropathic pain in primary care settings . F1000Posters 2011, 2:1533 (poster)

Effect of pregabalin on cost and clinical consequences in gabapentin-refractory patients with peripheral neuropathic pain in primary care settings

Ana Navarro, María Teresa Saldaña, Concepción Pérez, Xavier Masramón, Javier Rejas1
Published 07 Oct 2011
Author Affiliations
  • Metrics
  • 246 Views
  • 6 Downloads
 
Part of the collection
Browse by related subjects
Published 07 Oct 2011

Effect of pregabalin on cost and clinical consequences in gabapentin-refractory patients with peripheral neuropathic pain in primary care settings

[version 1; not peer reviewed]

Ana Navarro, María Teresa Saldaña, Concepción Pérez, Xavier Masramón, Javier Rejas1
Author Affiliations
1 Health Economics and Outcomes Research Department, pfizer, Spain
Presented at
7th Congress of the European Federation of IASP Chapters (EFIC) 2011
Abstract
Competing Interests

This study has been funded by Pfizer Inc.
Javier Rejas is an employee at Pfizer Spain

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.